MAT is the clinical standard of care for opioid use disorder. Suboxone, methadone, Vivitrol, and naltrexone are all typically covered by Kentucky Medicaid plans and reduce overdose mortality by more than half when continued long-term.
Kentucky Medicaid plans typically cover Suboxone, Subutex, methadone, Vivitrol, and oral naltrexone for opioid use disorder. Pick your plan to see specific formulations, authorization, and pharmacy benefit details.
See Aetna Better Health's MAT coverage detail.
View plan → Kentucky Medicaid planSee Anthem Medicaid's MAT coverage detail.
View plan → Kentucky Medicaid planSee Humana Healthy Horizons's MAT coverage detail.
View plan → Kentucky Medicaid planSee Passport's MAT coverage detail.
View plan → Kentucky Medicaid planSee UnitedHealthcare Community Plan's MAT coverage detail.
View plan → Kentucky Medicaid planSee WellCare's MAT coverage detail.
View plan →Coverage is determined by medical necessity. Call admissions and we'll verify your specific plan as part of the first call.
Buprenorphine + naloxone. Office-based daily sublingual dosing. Partial agonist with built-in misuse deterrent.
Learn more about Suboxone →Buprenorphine alone. Used during pregnancy when the naloxone in Suboxone isn't appropriate.
Learn more about Subutex →Full opioid agonist. Daily on-site dosing at a federally licensed Opioid Treatment Program (OTP).
Learn more about Methadone →Extended-release naltrexone. Monthly injection. Requires 7–14 days opioid-free before the first dose.
Learn more about Vivitrol →Daily oral antagonist. Pill form of the same medication as Vivitrol. Lower adherence than injection.
Yes. Kentucky Medicaid plans typically cover MAT for opioid use disorder. Pharmacy prior authorization may apply to specific formulations.
It depends on overdose risk, prior treatment history, pregnancy status, ability to attend daily dosing (for methadone), and personal preference. A Golden Grove clinician will help you choose during the assessment.
Yes. Subutex (buprenorphine alone, without naloxone) is the standard MAT for pregnant members with OUD, and is typically covered by Kentucky Medicaid plans. Methadone in an OTP is also a coverage option.
MAT is meant to be a long-term treatment for many patients. There is no clinical evidence that shorter MAT duration improves outcomes. Tapering, when appropriate, should be gradual and clinically guided.
24/7 admissions. Insurance verification in minutes. Most KY Medicaid plans accepted. No judgment, no pressure, no obligation.